Login / Signup

Aiming at the Right Targets on Drug Price Reform.

Stacie B Dusetzina
Published in: The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics (2024)
A lack of transparency and concerns over patients costs at the pharmacy counter have increased Congressional focus on pharmacy benefits management practices. However, applying regulations without transparency into pharmacy benefits managers practices could do more harm than good.
Keyphrases
  • end stage renal disease
  • primary care
  • healthcare
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • peritoneal dialysis
  • prognostic factors
  • emergency department
  • drug induced